0000886163-23-000044.txt : 20230710
0000886163-23-000044.hdr.sgml : 20230710
20230710184239
ACCESSION NUMBER: 0000886163-23-000044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230710
DATE AS OF CHANGE: 20230710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Espinoza Octavio
CENTRAL INDEX KEY: 0001905248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 231080830
MAIL ADDRESS:
STREET 1: C/O LIGAND PHARMACEUTICALS INC
STREET 2: 3911 SORRENTO VALLEY BOULEVARD, STE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0407
4
2023-06-30
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001905248
Espinoza Octavio
3911 SORRENTO VALLEY, SUITE 110
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-06-30
4
J
0
375
56.78
A
24517
D
Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).
By: /s/ Andrew Reardon For: Octavio Espinoza
2023-07-10